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Abstract 
Objective: The study was aimed at exploring a one-year course of depression in persons with 
type 2 diabetes and analysing demographic, disease-related and psychological variables that 
may predict persistent depressive symptoms. Patients and methods: One hundred patients 
from a randomly selected sample of 470 outpatients were found to be suffering from severe 
depressive symptoms. They were followed and re-examined for depression after one year. 
Baseline depression was assessed by the Center for Epidemiologic Studies-Depression scale 
(CES-D) and a face-to-face diagnostic interview relying on the DSM-IV. Non-parametric 
tests for between-group differences were used to compare patients who recovered from 
depression with those who still suffered from severe depressive symptoms. Multiple logistic 
regression was used to determine predictors of depression persistence. Results: Seventy-nine 
of 100 patients with baseline depression scores indicative of severe depression were reached 
at one-year follow-up. Among them, 53% were shown to have improved depressive 
symptoms to CES-D <16, while 47% continued to suffer from severe depressive disturbances 
(CES-D≥16). Logistic regression analysis indicated that psychosocial variables predicted 
persistently elevated depressive symptoms better than demographic and diabetes-related ones. 
Clinical depression at baseline (OR =3.8  /CI 1.31-10.98/  p=0.01), diabetes-related distress 
(OR=3.3  /CI 1.01-10.98/  p=0.05), and social and physical quality of life aspects (OR=0.92  
/CI 0.88-0.97/ p=0.0005 and OR=0.94  /CI 0.90-0.98/ p=0.002  respectively) were shown to 
be independent predictors of one-year depression outcomes. Conclusions: Severity of 
baseline depression, a degree to which depression disrupted the  patients' quality of life, and 
concomitant emotional problems related to diabetes were shown to be associated with 
persistently elevated depressive symptoms. 
Key words: depressive symptoms, type 2 diabetes, diabetes-related distress, quality of life, 
persistence of depression 
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1. Introduction 
There is a growing body of research on the relationship between diabetes mellitus and mood 
disorders aimed at understanding the interplay of somatic and psychological processes, and 
hypothesizing  mechanisms that may explain it. It has been supposed that diabetes-depression 
comorbidity may be due to the psychosocial burden of diabetes, biochemical changes related 
to diabetes and its treatment, or to a coincident occurrence of two highly prevalent diseases 
(Lustman et al., 1992)  A rewiev article by Talbot et al. (2000) indicated that psychosocial 
burden of having diabetes is a plausible explanation of the relationship between diabetes and 
depression, although this relationship may be bidirectional as well. A meta-analysis of 
longitudinal studies on depression as a risk factor for the onset of type 2  diabetes (Knol et al., 
2006) has indicated that depressed adults have a 37 percent increased risk of developing 
diabetes.The underlying pathophysiological mechanisms remain to be determined.   
Examining independent factors associated with depressive disorders in diabetes Egede et al. 
(2003) have found that perceptions about the effect of diabetes on overall health seem to play 
an important role in the etiology of depression in addition to other psychosocial factors such 
as age, gender, education and socioeconomic status. Perceived lack of control and illness 
intrusiveness have also been found to be associated with the development of depression in 
diabetic patients (Talbot et al., 1999). 
The analysis of  predictors of depression in a randomly selected sample of Croatian diabetic 
patients has shown that psychological factors are more strongly associated with the 
development of depressive symptoms than the disease-related variables. The psychological 
factors comprised variables referring to psychological well-being, subjective limitations due 
to emotional problems, and experienced social support ( Pibernik-Okanovic et al., 2005). 
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Research has shown that the prevalence of clinical depression in diabetic patients is 
approximately twice as high as in the general population (Anderson et al., 2001). Women, 
minorities and patients with lower socioeconomic status or physical disability are particularly 
at risk (Fisher et al., 2001). In persons with diabetes depression has been shown to be 
associated with poor self-care (Ciechanowsky et al., 2000) and increased risk of developing 
diabetes complications, including heart disease and cerebral infarction (De Groot et al., 2001). 
Comorbid depression in diabetic patients increases the risk of developing physical diseases, 
the need for health care and corresponding health care costs (Penninx et al., 1998; Greenberg 
et al., 1993). 
Once diagnosed, depression was shown to be recurrent in persons with diabetes (Lustman et 
al., 1988; Peyrot et al., 1997). Patients with more diabetes-related complications, non-insulin 
treated and less educated ones are more likely to suffer from persistent depressive 
disturbances (Peyrot et al., 1999). 
In addition to demographic and disease-related variables psychological factors may also be 
hypothesized to affect the course of depression in diabetic patients. A recent cross-cultural 
study by Pouwer et al. (2005) demonstrated that diabetes-specific emotional problems as 
measured by the Problem Areas in Diabetes scale (Welch et al., 1997) are particularly 
prevalent in depressed diabetic patients, suggesting possible interaction between depression 
and diabetes-related emotional distress. Whether specific vulnerabilities to the stress of living 
with diabetes affect long-term outcomes of depression remains to be determined. 
 This study was aimed at: 1) exploring one-year depression outcomes in patients found to be 
depressed by a random screening procedure for depression, and   2) determining predictors of 
persistent depressive symptoms at one-year follow-up. 
 
2. Patients and methods 
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An observational study design with a one-year follow-up was used. The study was carried out 
at the Vuk Vrhovac University Clinic, a referral center for the registration, treatment and 
follow-up of patients with diabetes mellitus in Croatia. 
The examined sample was found to be depressed among randomly selected diabetic 
outpatients (total number = 470) attending their regular check-ups. Patient records were 
marked one day prior to their scheduled appointment, at which patients' consent was 
requested. Psychological anamnesis and data on current life circumstances were collected by a 
semi-structured interview. Questionnaires assessing depressive symptoms (CES-D), problem 
areas in diabetes (PAID) and health-related quality of life (SF-12) were used to gain insight 
into the individuals' experience in living with their disease. Patients with CES-D scores ≥16  
were invited for a psychiatric interview relying on Axis I disorders of the DSM-IV (SCID) to 
establish the clinical significance of their symptoms. If not already treated, clinically 
depressed patients with confirmed diagnosis of either major depressive episode or dysthymic 
disorder were informed about the importance and the possibilities of depression treatment. 
Patients with CES-D scores≥16, but not confirmed by SCID, were considered as subclinically 
depressed and advised to seek treatment if their symptoms were subjectively intolerable or got 
worse. 
All patients with CES-D scores ≥16 were contacted by phone at 3-month intervals in order to 
check their current state and treatment seeking behavior, and re-examined for depression after 
one year. The retest CES-D scores <16 were considered  indicative of improvement.   
The participant flow diagram is presented in Figure 1. 
Disease-related data were collected from the patients' files. 
The study was approved by the Clinic's Ethics committee. 
 
2.1. Measures 
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Depressive symptoms were measured by Center for Epidemiological Studies Depression 
(CES-D) scale (Radloff et al., 1986). This is a 20-item, self-report scale that asks respondents 
to indicate the frequency of experiencing each of the 20 symptoms over the previous week. 
The instrument uses a 4-point response scale ranging from «rarely or none of the time» to 
«most or all of the time» with total scores ranging from 0 to 60. Higher scores indicate more 
severe depressive symptoms. A cut-point of ≥16 was considered  indicative of severe 
depression.  
Diabetes-related emotional distress was assessed by the Problem Areas in Diabetes (PAID) 
questionnaire (Welch et al., 1997). This is a 20-item, self-report scale that asks respondents to 
rate how much of a problem they find each of the 20 diabetes-related issues. The answers are 
given on a 5-point scale ranging from 0 («not a problem») to 4 («serious problem»). The 
PAID scores are summed (with total scores ranging from 0 to 80) and transformed to a 0-100 
scale with higher scores indicating more diabetes-related distress. Scores > 40 were 
considered indicative of high distress. 
The PAID scale was translated to Croatian in accordance with the generally accepted rules 
(translating, backtranslating, piloting) prior to the study and applied to 157 patients with 
different disease characteristics. The performed psychometric analysis indicated the translated 
scale's good internal consistency and construct validity, as well as factor loadings comparable 
to the original scale (Cronbach’s alpha=0.926; 3 factors explaining 42.6%, 6.6% and 6.1% of 
the variance, respectively). 
Health-related quality of life was assessed by the SF-12 v2 questionnaire which comprises 
self-assessments of general health, physical functioning, physical roles, bodily pain, vitality, 
social functioning, emotional roles and mental health. The raw scores for particular subscales 
are transformed to a 0-100 scale with higher scores indicating better health-related quality of 
life (Ware te al., 1996). 
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Clinical significance of depressive symptoms detected by the questionnaire was determined 
by structured clinical interview for DSM-IV Axis I Disorders – Clinician Version (SCID-CV) 
(First et al., 2000) conducted by a psychiatrist.  
HbA1c was determined by an automated immunoturbidimetric method using Bayer reagents 
(Tarrytown, Il, USA) on Olympus AU600 analyser (Olympus Optical Co., Tokyo, Japan) with 
a normal range from 3.5 to 5.7% (Vucic et al., 1999).  
 
2.2. Statistical analysis 
Subgroups of patients with and without severe depressive symptoms at follow-up were 
compared using the Mann-Whitney U test. Predictors of depression were determined by using 
multiple logistic regression with retest CES-D score <16 vs ≥16 as a dependent variable, and 
demographic (gender, age, education, economic status), disease-related (diabetes therapy, 
body mass index, glycemic regulation, concomitant diseases, presence/absence of a clinical 
diagnosis of depression at baseline) and psychological variables (quality of life and diabetes-
related distress) as independent variables. Three subsequent models of hypothetical predictors 
were tested: Model 1 containing demographic and disease-related variables, i.e. gender, age, 
insulin therapy, BMI, concomitant diseases, glycemic control, education, economic status and 
baseline severity of depression; Model 2 comprising variables included in Model 1+PAID 
scores ; and Model 3 including Model 1+SF-12 scores. The last model was tested by adding 
SF-12 subscales to variables from Model 1 one at a time. Social functioning and Role 
physical subscales were observed as having the highest predictive value and were for this 
reason analysed in Model 3. The underlying rationale for using three different models was to 
a) check predictive value of demographic and disease-related factors known from the 
literature (Model 1), b) examine a hypothetical contribution of diabetes-specific distress to 
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persistent depressive symptoms (Model 2), and c) examine a hypothetical contribution of 
diabetes non-specific quality of life to persistently elevated depressive symptoms (Model 3). 
 
3. Results 
Seventy-nine patients with baseline CES-D scores ≥16 were reached at one-year follow-up.  
The attenders did not differ from non-attenders with respect to gender, age, education, 
duration of diabetes, diabetes therapy, body mass index, glycemic control and baseline CES-D 
scores (all P>.05). 
As presented in Table 1, 53% (N=42) of the initially depressed patients reached at follow-up 
improved their depressive symptoms, while 47% (N=37) remained above the cut-off. Patients 
who recovered from severe depressive symptoms and those still severely depressed were of 
comparable age (p=0.73), sex distribution (p=0.38), education (p=0.53), diabetes duration 
(p=0.91) and insulin treatment (p=0.93). They did not differ in the number of concomitant 
diseases (p=0.39), BMI (p=0.30), HbA1c (p=0.96), and the presence of cardiopathy (p=0.91), 
neuropathy (p=0.80) and retinopathy (p=0.87). Comparable proportions of patients from the 
two groups reported previous psychological problems (p=0.36). There was no significant 
difference in proportions of patients from the two groups who were treated for psychological 
problems at baseline (p=0.22) and during the follow-up period (p=0.27). A tendency towards 
poorer economic status was indicated in the group with persistent depression, but was not 
statistically significant (p=0.07). 
The patients with persistent symptoms had higher baseline CES-D scores (p<0.001), were 
more frequently classified as clinically depressed (p<0.01), and had lower baseline scores at 
all SF-12 subscales excepting Mental health subscale (Physical functioning p= 0.001; Role 
physical p=0.0001; Bodily pain p=0.01; General health    p=0.005; Vitality p=0.04; Social 
functioning p=0.0005; Role emotional p=0.02; Mental health p=0.16). Although a higher 
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level of diabetes-related distress was observed in the group with persistent depressive 
symptoms, a statistical significance was not reached (p=0.20). However, the proportion of 
patients with baseline PAID scores above the median of the entire group was significantly 
higher in the persistently depressed group (p=0.05).   
As presented in Table 2,  Model 1 including demographic and disease-related variables was 
not shown to predict one-year depression outcomes  as a whole ( χ²=10.8  p= 0.37  
Nagelkerke R2= 0.167). However, baseline severity of depression, defined as either the 
presence or absence of clinical diagnosis of depression, independently predicted persistence 
of or recovery from depressive symptoms (Wald's χ²=6.32  p=0.01   OR =3.8   CI 1.31-10.98). 
More severe baseline depressive symptoms, i.e. a clinical diagnosis of either major depressive 
episode or dysthymia was shown to increase the possibility of persistent depressive symptoms 
after a one-year follow-up.  
Model 2, integrating demographic and disease-related variables with the PAID scores, did not 
reach statistical significance as a whole. Nevertheless, the variance it explained increased in 
comparison with Model 1 ( χ²= 14.9  p= 0.19   Nagelkerke R2=0.229). PAID scores above the 
median of the whole group were shown to independently predict persistent depressive 
symptoms (Wald's χ²= 3.9 p=0.05 OR=3.3  CI 1.01-10.98), indicating that very severe 
diabetes-related distress in addition to depression increased the likelihood of suffering from 
persistent depressive disturbances.  
Model 3, integrating demographic and disease-related variables with social and physical 
quality of life scores, was shown to significantly predict one-year outcomes, i.e. persistent vs 
improved depressive symptoms (χ²= 47.25    p<0.00001  Nagelkerke R2= 0.499). Both Social 
functioning and Role physical subscales independently predicted persistently elevated 
depressive symptoms (OR= 0.92; CI 0.88-0.97   p=0.0005 and OR= 0.94  CI  0.90-0.98  
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p=0.002, respectively), indicating that better diabetes non-specific quality of life  was shown 
to have a protective role and diminished the likelihood of persistent depressive symptoms. 
4. Discussion 
The obtained data demonstrated that depressive mood was persistent in a considerable 
proportion of  the examined sample – approximately half of patients found to be depressed at 
baseline had CES-D scores indicative of pervasive depression at the one-year follow-up. Even 
the patients who improved depressive symptoms scoring to less than 16 at the follow-up CES-
D scale may be considered to have residual symptoms that include an increased risk from 
depression recurrence (Keller, M.B., 2004).  
The obtained indicators of persistent depressive symptomatology are in accordance with other 
published data suggesting that depression is an ongoing disease in patients with diabetes. The 
study by Lustman et al. (1997) has demonstrated that patients diagnosed with major 
depression had an average of 5 episodes during a 5-year follow-up period. The recurrence rate 
in the first year was high even in patients who improved their mood during a placebo 
controlled trial of nortriptilyne. Persistence of depressive symptoms was also found in a 
substantial proportion of subclinically depressed patients, accompanied by a slight tendency 
to adversely affect glycemic control (Hermanns et al., 2004).  
The study by Peyrot et al. (1999) has demonstrated that 13% of the examined adults with 
diabetes were persistently depressed at three time points during a six-month follow-up period. 
This relatively small proportion could be due to the coping skills training the examined 
patients received as part of the psychoeducational intervention.  
Twenty-four percent of patients who improved their depressive symptoms  and 38% of those  
with persistent severe symptoms were treated by antidepressant therapy between the baseline 
and the follow-up assessment. The small proportion of treated patients may suggest that 
patients' readiness to accept treatment recommended at baseline was relatively low. Since not 
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all, but only clinically depressed patients were encouraged to engage in depression therapy, 
the compliance rate is actually higher – approximately 60% of the patients accepted 
recommended treatment, while some of the subclinically depressed patients sought 
professional help on their own. This suggests that screening patients for depression and 
encouraging them to take care of it may increase the currently low response rates to 
depression treatment in diabetic population (Rubin et al., 2004).         
Persistent depression in the examined sample was not shown to be associated with 
demographic and disease-related variables (gender, age, education, economic status, duration 
of diabetes, diabetes treatment, glycemic control, presence of diabetes complications and 
concomitant diseases), all of which were comparable in both patients who recovered from 
depression and those who persisted in severe depressive symptoms. This is not quite in 
accordance with the previously reported findings indicating that poorly educated patients, 
those with more than two complications and non-insulin treated ones were more likely to 
persist in depressive symptoms (Peyrot et al., 1999). In the intervention study by Lustman et 
al., (1998), nonremission of depression was associated with lower compliance with blood 
glucose monitoring, higher glycated hemoglobin, higher weight and a history of depression. 
However, diabetes control and  psychological anamnesis were not shown to be discriminative 
in our subgroups with different outcomes. What did count in the one-year course of 
depression was the baseline severity of depression defined in terms of clinical diagnosis, 
emotional problems due to diabetes, and the extent to which depression ruined the individuals' 
quality of life, particularly their physical and social functioning.  
Perceived health-related quality of life varies in patients with comparable health conditions. 
Published results have indicated that depression is significantly related to self-reported quality 
of life even when differences in physical health and age have been statistically controlled for 
(Kohen et al., 1998). Our results have shown that the interaction between depression and 
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quality of life in patients with diabetes can be hypothesized to be associated with persistence 
of depression as well. Perceived quality of life seems to have a protective role with respect to 
depression persistence. Persisent symptoms seemed less likely in individuals whose subjective 
quality of life was less disrupted by depressive symptoms than in those with more negative 
depression : quality of life interaction. This particularly referred to the individuals' social 
functioning, and the degree to which they perceived their physical roles as being limited. The 
groups' comparability regarding both diabetes- and concomitant diseases' status suggests that 
subjective rather than objective health status may play a role in experiencing a long time 
depression. 
Baseline severity of depression defined either as clinical diagnosis of depression or 
subclinical depressive symptoms was shown to predict the persistence of depression as well. 
Clinical cases are more likely to suffer from prolonged depressive symptoms than the 
subclinical ones. Suprisingly, one-year depression outcomes were not associated with 
depresion treatment. Patients found to be clinically depressed at baseline were encouraged to 
engage in depression therapy. Approximately 60% of them accepted the recommendation and 
were pharmacologically treated during the follow-up period. Probably due to the small 
number of patients in the two groups (15 treated vs 11 not treated), the treated patients did not 
reveal significantly better outcomes, although a tendency towards an improvement was 
indicated in the treated individuals. 
Diabetes-related distress was shown to be associated with long-term depression outcomes in 
addition to its baseline severity and impact on quality of life. Depressed patients are generally 
more likely to experience serious diabetes-related emotional problems (Pouwer et al., 2005). 
Whether diabetes-related distress increases the possibility to develop depressive symptoms, or 
depressive mood makes individuals more vulnerable to such a distress remains unanswered. 
Very likely, a two-way relationship between the two disturbances may be hypothesized. 
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Certainly, when present in depressed patients as a concomitant condition, diabetes-related 
emotional problems in addition to the severity of depression and subjectively perceived 
quality of life predict the course of depressive symptoms and are associated with long-term 
patients' outcomes.  
In conclusion, the obtained results suggest that psychological factors are associated with the 
course of depressive symptoms in type 2 diabetic patients by making the symptoms persistent. 
This is especially true for factors that are connected with the examined individuals' subjective 
experience of diabetes and overall health condition,. 
From a clinical point of view, these findings suggest that increased attention should be given 
to patients whose depressive disturbances are combined with serious emotional problems 
related to diabetes. Assessing diabetes-related distress in addition to assessing depressive 
symptoms may be recommended in order to better understand patients' needs and provide 
them with appropriate treatment. Depression treatment addressing specific diabetes-related 
problems may be expected to improve the outcomes. 
The limitations of this study are a relatively small number of patients, and the fact that not all 
of them could be reached at the one-year follow-up. However, a random sampling procedure 
among patients regularly attending their outpatient visits, and the fact that patients who were 
not available at follow-up did not differ from the attenders, may support the validity of these 
findings. 
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Figure 1: Participant flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
470 randomly selected outpatients assessed for 
depression (CES-D) 
Diabetes-related distress (PAID) and quality of 
life (SF-12) assessed in addition to depression 
79 patients reached at 
one-year follow-up 
37 patients still had 
elevated depressive 
symptoms CES-D≥16 
42 patients 
improved depressive 
symptoms (CES-
100 patients found to suffer from 
severe depressive symptoms 
(CES-D≥16) 
370 patients had CES-D scores 
<16 
30 patients confirmed by 
SCID as clinically 
depressed 
70 patients not 
confirmed by SCID; 
regarded as subclinically 
21 patients not reached (14 refused 
re-assessment; 2 hospitalized; 3 
died; 2 worsened health condition) 
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Table 1: Comparisons between the group with depressive symptoms improved to  
              CES-D<16 and the group with persistent CES-D scores ≥ 16  
 CES-D<16 
n=42 
CES-D≥16 
n=37 
 
P 
% female 71 62 .38 
Age 55 (50-63) 57 (53-61) .73 
Education (yrs) 11 (8-12) 11 (8-12) .53 
Socioeconomic status (% very poor) 21 41 .07 
Duration of diabetes 9.5 (5-12) 9 (4-14) .91 
% insulin treated 52 51 .93 
HbA1C at baseline 7.9 (7.2-8.9) 7.6 (6.8-9.4) .73 
HbA1C at follow-up 7.8 (6.8-8.4) 7.5 (6.7-9.4) .96 
Body mass index (kg/m2) 29.2 (26.7-32.6) 28 (26-31) .30 
% with cardiopathy 29 30 .91 
% with neuropathy 40 43 .80 
% with retinopathy 28 27 .87 
% with more than one concomitant disease 66 57 .39 
% with previous psychological problems 60 70 .36 
% receiving psychopharmaceuticals at baseline 
(not exclusively for depression)  
43 57 .22 
Baseline CES-D score 19 (16-26) 25 (22-35) .0001** 
% clinically depressed (SCID) 18 48 .001** 
% treated for depression during the follow-up  24 38 .27 
PAID scores 49 (35-62) 56 (36-68) .20 
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% with PAID scores above 49 (the entire 
group's median) 
 
21 
 
29 
 
.05* 
Physical functioning (SF-12) 50 (50-75) 50 (25-50) .001** 
Role physical (SF-12) 50 (50-75) 50 (25-50) .0001** 
Bodily pain (SF-12) 75 (25-75) 25 (25-50) .01** 
General health (SF-12) 25 (25-61) 25 (0-25) .005** 
Vitality (SF-12) 50 (25-50) 25 (25-50) .04* 
Social functioning (SF-12) 75 (50-75) 50 (25-50) .0005** 
Role emotional (SF-12) 75 (50-75) 50 (38-50) .02* 
Mental health (SF-12) 50 (38-50) 38 (25-50) .16 
CES-D at follow-up 10 (7-13) 24 (19-31) .0001** 
 
Data are expressed as medians (interquartile range) or frequences.  P values refer to either 
Mann-Whitney U test or χ² test. 
 
Table 2: Logistic regression analysis of one-year depression outcomes: persistent vs 
    improved depressive symptoms  
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The entire model’s  χ²=10.8       p= 0.37    Nagelkerke R2=.167 
 
Model 2   
Coeff. Standard 
error 
Wald's χ² p 
value 
Odds 
ratio 
95% CI 
Gender -0.53 0.60 0.78 0.38 0.59 0.18-1.96 
Age 0.001 0.03 0.001 0.97 1.00 0.94-1.07 
Education -0.03 0.09 0.13 0.72 0.97 0.80-1.16 
Socioeconomic status -0.11 0.41 0.08 0.78 0.89 0.39-2.03 
Insulin therapy -0.18 0.31 0.35 0.56 0.84 0.45-1.54 
Body mass index -0.88 0.07 1.72 0.19 0.92 0.80-1.05 
Concomitant diseases 0.34 0.43 0.61 0.43 1.40 0.59-3.32 
HbA1C 0.14 0.24 0.33 0.57 1.15 0.71-1.88 
Baseline severity of depression 1.26 0.54 5.42 0.02 3.54 1.20-10.45 
PAID scores >49 1.19 0.61 3.89 0.05 3.28 1.01-10.98 
The entire model’s  χ²=14.86     p=0.19   Nagelkerke R2=.229 
 
 
Model 1  
Coeff. Standard 
error 
Wald's χ² p 
value 
Odds 
ratio 
95% CI 
Gender -0.40 0.58 0.47 0.49 0.67 0.21-2.12 
Age 0.0003 0.03 0.0001 0.99 1.00 0.94-1.06 
Education -0.04 0.09 0.20 0.66 0.96 0.80-1.15 
Socioeconomic status 0.13 0.39 0.11 0.74 1.14 0.53-2.45 
Insulin therapy -0.12 0.29 0.16 0.69 0.89 0.50-1.58 
Body mass index -0.07 0.06 1.31 0.25 0.89 0.50-1.58 
Concomitant diseases 0.36 0.42 0.74 0.39 1.43 0.62-3.29 
HbA1C 0.12 0.24 0.24 0.62 1.12 0.70-1.80 
Baseline severity of depression  1.34 0.53 6.32 0.01 3.80 1.31-10.98 
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Model 3   
Coeff. Standard 
error 
Wald's χ² p 
value 
Odds 
ratio 
95% CI 
Gender -0.90 0.67 1.78 0.18 0.41 0.11-1.56 
Age 0.05 0.05 1.41 0.23 1.06 0.96-1.16 
Education -0.22 0.13 2.81 0.09 0.80 0.61-1.04 
Socioeconomic status -0.71 0.55 1.65 0.20 0.49 0.16-1.49 
Insulin therapy -0.63 0.39 2.54 0.11 0.54 0.24-1.17 
Body mass index -0.11 0.08 2.24 0.13 0.89 0.77-1.04 
Concomitant diseases 0.41 0.48 0.72 0.40 1.51 0.57-3.94 
HbA1C 0.49 0.31 2.48 0.12 1.64 0.88-3.08 
Baseline severity of depression 1.18 0.73 2.60 0.11 3.25 0.75-14.00 
Role physical (SF- 12) -0.06 0.02 9.20 0.002 0.94 0.90-0.98 
Social functioning (SF-12) -0.08 0.02 11.87 0.0005 0.92 0.88-0.97 
The entire model’s  χ²=47.25    p<0.000001  Nagelkerke R2 =.499 
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